TickerFacts.

Relmada Therapeutics, Inc. (RLMD): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-5, first reflected in a filing dated 2015-09-11. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

73.33M
As of 2025-12-31
106.67M
As of 2026-06-30
+34.6%
3-year compound annual growth
+35.0%
5-year compound annual growth
2014-06-30: 8.06M2015-06-30: 10.78M2016-06-30: 12.04M2017-06-30: 12.53M2018-06-30: 12.55M2019-06-30: 9.74M2019-12-31: 14.46M2020-12-31: 16.33M2021-12-31: 27.74M2022-12-31: 30.10M2023-12-31: 30.10M2024-12-31: 30.17M2025-12-31: 73.33M73.33M
2014-06-30 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3173.33M+143.0%2026-03-19, Balance as of period end
2024-12-3130.17M+0.2%2026-03-19, Balance as of period end
2023-12-3130.10M0.0%2025-03-27, Balance as of period end
2022-12-3130.10M+8.5%2024-03-19, Balance as of period end
2021-12-3127.74M+69.8%2023-03-23, Balance as of period end
2020-12-3116.33M+13.0%2022-03-25, Balance as of period end
2019-12-3114.46Mn/a2021-03-24, Balance as of period end
2019-06-309.74M-22.4%2021-03-24, Balance as of period end
2018-06-3012.55M+0.2%2019-09-24, Balance as of period end
2017-06-3012.53M+4.1%2018-09-28, Balance as of period end
2016-06-3012.04M+11.7%2017-09-28, Balance as of period end
2015-06-3010.78M+33.7%2016-09-09, Balance as of period end
2014-06-308.06Mn/a2015-09-11, Balance as of period end